Clear. 58.8   F New York
AI-Powered News Summarizer
Top Stories

US government moves AstraZeneca out of vaccine plant that suffered contamination

April 4, 2021. Summarized by summa-bot.

Compression ratio: 75.8%. 1 min read.

The federal government has moved to stop any further risk of contamination at a Baltimore contract vaccine manufacturer where 15 million potential doses of Johnson & Johnson vaccine were spoiled last month, telling rival drugmaker AstraZeneca it must move its production from the plant and find somewhere else to make its vaccine.

The federal government has moved to stop any further risk of contamination at a Baltimore contract vaccine manufacturer where 15 million potential doses of Johnson & Johnson vaccine were spoiled last month, telling rival drugmaker AstraZeneca it must move its production from the plant and find somewhere else to make its vaccine.

The Emergent BioSolutions plant in Baltimore was making coronavirus vaccines under contract to both Johnson & Johnson and AstraZeneca.

Last month, a batch of Johnson & Johnson "drug product" failed quality controlĀ and was taken out of production, both J&J and Emergent have said.

The federal government has directed Johnson & Johnson to fully take over its vaccine production at the plant, an administration official told CNN Saturday.

The Emergent BioSolutions plant, which had been making doses of both Johnson & Johnson's vaccine as well as a vaccine made for AstraZeneca, will now only produce J&J vaccines, the official said.

"Johnson & Johnson is assuming full responsibility regarding the manufacturing of drug substance for its COVID-19 vaccine at the Emergent BioSolutions Inc. Bayview facility," the company said in a statement emailed to CNN.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.

Suggestions